Business
Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025
LAKE FOREST, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the iAccess Alpha Best Ideas Spring Investment Conference taking place virtually March 25-26, 2025. The Company will present at 1:30 pm Eastern Time on Tuesday, March 25, 2025. To join the presentation, please visit the webcast available online at https://investor.assertiotx.com/. Additionally, in
About this update from Assertio Holdings, Inc.
[{"type":"image","alt":"Assertio Holdings, Inc.","displaySize":"","headline":null,"caption":"Assertio Holdings, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":258,"height":65,"url":"https://media.zenfs.com/en/globenewswire.com/da1bca653bc4f6a56d9f42c854c5ee83"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GWZkt7ZOPvh6mbIYky9FKg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwNjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/da1bca653bc4f6a56d9f42c854c5ee83","width":258,"height":65}},"lazy":false},{"type":"text","content":"LAKE FOREST, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the iAccess Alpha Best Ideas Spring Investment Conference taking place virtually March 25-26, 2025.","length":301,"tagName":"p"},{"type":"text","content":"The Company will present at 1:30 pm Eastern Time on Tuesday, March 25, 2025. To join the presentation, please visit the webcast available online at https://investor.assertiotx.com/.","length":181,"tagName":"p"},{"type":"text","content":"Additionally, investors participating in the conference can request 1x1 meetings to take place on March 26, 2025 via their conference representative or through Assertio investor relations at [email protected]. To register to attend the conference and request 1x1 meetings, please visit https://www.iaccessalpha.com/.","length":318,"tagName":"p"},{"type":"text","content":"About Assertio ","length":14,"tagName":"p"},{"type":"text","content":"Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com.","length":308,"tagName":"p"},{"type":"text","content":"Investor Contact","length":16,"tagName":"p"},{"type":"text","content":"Matt Kreps, Managing DirectorDarrow AssociatesM: [email protected]","length":83,"tagName":"p"},{"type":"text","content":"Forward-Looking Statements","length":26,"tagName":"p"},{"type":"text","content":"Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio’s current expectations, assum...